The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing

The purpose of this study was to determine the validity of the Osteoporosis Risk Assessment Instrument (ORAI), Osteoporosis Self-Assessment Tool (OST) chart and equation, and a criterion based on body weight for identifying women with asymptomatic primary osteoporosis. Prospective recruitment and ch...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Osteoporosis international 2004-05, Vol.15 (5), p.361-366
Hauptverfasser: CADARETTE, Suzanne M, MCISAAC, Warren J, HAWKER, Gillian A, JAAKKIMAINEN, Liisa, CULBERT, Alison, ZARIFA, Gihane, OLA, Ebele, JAGLAL, Susan B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 366
container_issue 5
container_start_page 361
container_title Osteoporosis international
container_volume 15
creator CADARETTE, Suzanne M
MCISAAC, Warren J
HAWKER, Gillian A
JAAKKIMAINEN, Liisa
CULBERT, Alison
ZARIFA, Gihane
OLA, Ebele
JAGLAL, Susan B
description The purpose of this study was to determine the validity of the Osteoporosis Risk Assessment Instrument (ORAI), Osteoporosis Self-Assessment Tool (OST) chart and equation, and a criterion based on body weight for identifying women with asymptomatic primary osteoporosis. Prospective recruitment and chart abstractions from family practices of three University affiliated hospitals were completed for women aged 45 years or more with baseline bone mineral density (BMD) testing results by dual energy X-ray absorptiometry. Those taking bone active medication other than hormone therapy, with prior fragility fracture or with risk factors for secondary osteoporosis were excluded. Women were categorized as being normal, osteopenic or osteoporotic by lowest BMD T-score at either the femoral neck or lumbar spine (L1-L4). Sensitivity, specificity and area under the receiver operating characteristic (ROC) curve to identify those with osteoporosis were determined for each decision rule. The positive predictive value (PPV) for detecting osteoporosis after using a second cut point to convert each decision rule into a risk index (low, moderate or high risk) was also determined. The sensitivity of the decision rules to identify women with osteoporosis ranged from 92% to 95% and specificity from 35% to 46%. The area under the ROC curves were significantly better for the ORAI (0.80), OST chart (0.82) and OST equation (0.82) compared with the body weight criterion (0.73). PPV for detecting osteoporosis ranged from 30% to 58% among women deemed at high risk. These data confirm the validity of the ORAI, the OST chart and the OST equation as screening tools for BMD testing. Further evidence is required to confirm the validity of the body weight criterion.
doi_str_mv 10.1007/s00198-003-1552-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71856455</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71856455</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-132df8f7fed2ff921f3522b65f2aabea063eef358d276021d747bb80f6c8df153</originalsourceid><addsrcrecordid>eNpdkc1q3DAURkVJ6EzSPkA3QRSanRNdybLsZQn9g4FsEuhOyPZVo8GWJpKdIW9fmTEEshKI8x3p3o-QL8BugDF1mxiDpi4YEwVIyQv1gWyhFKLgTSXPyJY1QhVNCX835CKlPcuZplEfyQZKJVjJYUvGhyekL2ZwvZteabC0x84lFzyN84CJ2hBpwgG7yfl_9BhG9PTopid6iG40MUfShOEQYkjuRLfBIx2dx2iGbPNpEU-YFsEncm7NkPDzel6Sx58_Hu5-F7v7X3_uvu-KTshyKkDw3tZWWey5tQ0HKyTnbSUtN6ZFwyqBmO_qnquKcehVqdq2Zrbq6t6CFJfk-uQ9xPA857f16FKHw2A8hjlpBbWsSrmAX9-B-zBHn_-mOdQLJCBDcIK6PGWKaPU6vAamlyL0qQidi9BLEVrlzNUqntsR-7fEuvkMfFsBkzoz2Gh8XvwbJxUAKC7-A_nvknM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218856431</pqid></control><display><type>article</type><title>The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>CADARETTE, Suzanne M ; MCISAAC, Warren J ; HAWKER, Gillian A ; JAAKKIMAINEN, Liisa ; CULBERT, Alison ; ZARIFA, Gihane ; OLA, Ebele ; JAGLAL, Susan B</creator><creatorcontrib>CADARETTE, Suzanne M ; MCISAAC, Warren J ; HAWKER, Gillian A ; JAAKKIMAINEN, Liisa ; CULBERT, Alison ; ZARIFA, Gihane ; OLA, Ebele ; JAGLAL, Susan B</creatorcontrib><description>The purpose of this study was to determine the validity of the Osteoporosis Risk Assessment Instrument (ORAI), Osteoporosis Self-Assessment Tool (OST) chart and equation, and a criterion based on body weight for identifying women with asymptomatic primary osteoporosis. Prospective recruitment and chart abstractions from family practices of three University affiliated hospitals were completed for women aged 45 years or more with baseline bone mineral density (BMD) testing results by dual energy X-ray absorptiometry. Those taking bone active medication other than hormone therapy, with prior fragility fracture or with risk factors for secondary osteoporosis were excluded. Women were categorized as being normal, osteopenic or osteoporotic by lowest BMD T-score at either the femoral neck or lumbar spine (L1-L4). Sensitivity, specificity and area under the receiver operating characteristic (ROC) curve to identify those with osteoporosis were determined for each decision rule. The positive predictive value (PPV) for detecting osteoporosis after using a second cut point to convert each decision rule into a risk index (low, moderate or high risk) was also determined. The sensitivity of the decision rules to identify women with osteoporosis ranged from 92% to 95% and specificity from 35% to 46%. The area under the ROC curves were significantly better for the ORAI (0.80), OST chart (0.82) and OST equation (0.82) compared with the body weight criterion (0.73). PPV for detecting osteoporosis ranged from 30% to 58% among women deemed at high risk. These data confirm the validity of the ORAI, the OST chart and the OST equation as screening tools for BMD testing. Further evidence is required to confirm the validity of the body weight criterion.</description><identifier>ISSN: 0937-941X</identifier><identifier>EISSN: 1433-2965</identifier><identifier>DOI: 10.1007/s00198-003-1552-7</identifier><identifier>PMID: 14730421</identifier><language>eng</language><publisher>London: Springer</publisher><subject>Absorptiometry, Photon ; Age Factors ; Aged ; Ambulatory care ; Asymptomatic ; Biological and medical sciences ; Bone density ; Decision making ; Decision Support Techniques ; Diseases of the osteoarticular system ; Endocrine therapy ; Epidemiologic Methods ; Female ; Fractures ; Health sciences ; Humans ; Mass Screening - methods ; Medical sciences ; Middle Aged ; Osteoporosis ; Osteoporosis, Postmenopausal - diagnosis ; Osteoporosis, Postmenopausal - etiology ; Osteoporosis. Osteomalacia. Paget disease ; Patient Selection ; Risk assessment ; Risk Assessment - methods ; Risk factors ; Validity ; Womens health</subject><ispartof>Osteoporosis international, 2004-05, Vol.15 (5), p.361-366</ispartof><rights>2004 INIST-CNRS</rights><rights>International Osteoporosis Foundation and National Osteoporosis Foundation 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c354t-132df8f7fed2ff921f3522b65f2aabea063eef358d276021d747bb80f6c8df153</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15711172$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14730421$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CADARETTE, Suzanne M</creatorcontrib><creatorcontrib>MCISAAC, Warren J</creatorcontrib><creatorcontrib>HAWKER, Gillian A</creatorcontrib><creatorcontrib>JAAKKIMAINEN, Liisa</creatorcontrib><creatorcontrib>CULBERT, Alison</creatorcontrib><creatorcontrib>ZARIFA, Gihane</creatorcontrib><creatorcontrib>OLA, Ebele</creatorcontrib><creatorcontrib>JAGLAL, Susan B</creatorcontrib><title>The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing</title><title>Osteoporosis international</title><addtitle>Osteoporos Int</addtitle><description>The purpose of this study was to determine the validity of the Osteoporosis Risk Assessment Instrument (ORAI), Osteoporosis Self-Assessment Tool (OST) chart and equation, and a criterion based on body weight for identifying women with asymptomatic primary osteoporosis. Prospective recruitment and chart abstractions from family practices of three University affiliated hospitals were completed for women aged 45 years or more with baseline bone mineral density (BMD) testing results by dual energy X-ray absorptiometry. Those taking bone active medication other than hormone therapy, with prior fragility fracture or with risk factors for secondary osteoporosis were excluded. Women were categorized as being normal, osteopenic or osteoporotic by lowest BMD T-score at either the femoral neck or lumbar spine (L1-L4). Sensitivity, specificity and area under the receiver operating characteristic (ROC) curve to identify those with osteoporosis were determined for each decision rule. The positive predictive value (PPV) for detecting osteoporosis after using a second cut point to convert each decision rule into a risk index (low, moderate or high risk) was also determined. The sensitivity of the decision rules to identify women with osteoporosis ranged from 92% to 95% and specificity from 35% to 46%. The area under the ROC curves were significantly better for the ORAI (0.80), OST chart (0.82) and OST equation (0.82) compared with the body weight criterion (0.73). PPV for detecting osteoporosis ranged from 30% to 58% among women deemed at high risk. These data confirm the validity of the ORAI, the OST chart and the OST equation as screening tools for BMD testing. Further evidence is required to confirm the validity of the body weight criterion.</description><subject>Absorptiometry, Photon</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Ambulatory care</subject><subject>Asymptomatic</subject><subject>Biological and medical sciences</subject><subject>Bone density</subject><subject>Decision making</subject><subject>Decision Support Techniques</subject><subject>Diseases of the osteoarticular system</subject><subject>Endocrine therapy</subject><subject>Epidemiologic Methods</subject><subject>Female</subject><subject>Fractures</subject><subject>Health sciences</subject><subject>Humans</subject><subject>Mass Screening - methods</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Osteoporosis</subject><subject>Osteoporosis, Postmenopausal - diagnosis</subject><subject>Osteoporosis, Postmenopausal - etiology</subject><subject>Osteoporosis. Osteomalacia. Paget disease</subject><subject>Patient Selection</subject><subject>Risk assessment</subject><subject>Risk Assessment - methods</subject><subject>Risk factors</subject><subject>Validity</subject><subject>Womens health</subject><issn>0937-941X</issn><issn>1433-2965</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkc1q3DAURkVJ6EzSPkA3QRSanRNdybLsZQn9g4FsEuhOyPZVo8GWJpKdIW9fmTEEshKI8x3p3o-QL8BugDF1mxiDpi4YEwVIyQv1gWyhFKLgTSXPyJY1QhVNCX835CKlPcuZplEfyQZKJVjJYUvGhyekL2ZwvZteabC0x84lFzyN84CJ2hBpwgG7yfl_9BhG9PTopid6iG40MUfShOEQYkjuRLfBIx2dx2iGbPNpEU-YFsEncm7NkPDzel6Sx58_Hu5-F7v7X3_uvu-KTshyKkDw3tZWWey5tQ0HKyTnbSUtN6ZFwyqBmO_qnquKcehVqdq2Zrbq6t6CFJfk-uQ9xPA857f16FKHw2A8hjlpBbWsSrmAX9-B-zBHn_-mOdQLJCBDcIK6PGWKaPU6vAamlyL0qQidi9BLEVrlzNUqntsR-7fEuvkMfFsBkzoz2Gh8XvwbJxUAKC7-A_nvknM</recordid><startdate>20040501</startdate><enddate>20040501</enddate><creator>CADARETTE, Suzanne M</creator><creator>MCISAAC, Warren J</creator><creator>HAWKER, Gillian A</creator><creator>JAAKKIMAINEN, Liisa</creator><creator>CULBERT, Alison</creator><creator>ZARIFA, Gihane</creator><creator>OLA, Ebele</creator><creator>JAGLAL, Susan B</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20040501</creationdate><title>The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing</title><author>CADARETTE, Suzanne M ; MCISAAC, Warren J ; HAWKER, Gillian A ; JAAKKIMAINEN, Liisa ; CULBERT, Alison ; ZARIFA, Gihane ; OLA, Ebele ; JAGLAL, Susan B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-132df8f7fed2ff921f3522b65f2aabea063eef358d276021d747bb80f6c8df153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Absorptiometry, Photon</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Ambulatory care</topic><topic>Asymptomatic</topic><topic>Biological and medical sciences</topic><topic>Bone density</topic><topic>Decision making</topic><topic>Decision Support Techniques</topic><topic>Diseases of the osteoarticular system</topic><topic>Endocrine therapy</topic><topic>Epidemiologic Methods</topic><topic>Female</topic><topic>Fractures</topic><topic>Health sciences</topic><topic>Humans</topic><topic>Mass Screening - methods</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Osteoporosis</topic><topic>Osteoporosis, Postmenopausal - diagnosis</topic><topic>Osteoporosis, Postmenopausal - etiology</topic><topic>Osteoporosis. Osteomalacia. Paget disease</topic><topic>Patient Selection</topic><topic>Risk assessment</topic><topic>Risk Assessment - methods</topic><topic>Risk factors</topic><topic>Validity</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CADARETTE, Suzanne M</creatorcontrib><creatorcontrib>MCISAAC, Warren J</creatorcontrib><creatorcontrib>HAWKER, Gillian A</creatorcontrib><creatorcontrib>JAAKKIMAINEN, Liisa</creatorcontrib><creatorcontrib>CULBERT, Alison</creatorcontrib><creatorcontrib>ZARIFA, Gihane</creatorcontrib><creatorcontrib>OLA, Ebele</creatorcontrib><creatorcontrib>JAGLAL, Susan B</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Osteoporosis international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CADARETTE, Suzanne M</au><au>MCISAAC, Warren J</au><au>HAWKER, Gillian A</au><au>JAAKKIMAINEN, Liisa</au><au>CULBERT, Alison</au><au>ZARIFA, Gihane</au><au>OLA, Ebele</au><au>JAGLAL, Susan B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing</atitle><jtitle>Osteoporosis international</jtitle><addtitle>Osteoporos Int</addtitle><date>2004-05-01</date><risdate>2004</risdate><volume>15</volume><issue>5</issue><spage>361</spage><epage>366</epage><pages>361-366</pages><issn>0937-941X</issn><eissn>1433-2965</eissn><abstract>The purpose of this study was to determine the validity of the Osteoporosis Risk Assessment Instrument (ORAI), Osteoporosis Self-Assessment Tool (OST) chart and equation, and a criterion based on body weight for identifying women with asymptomatic primary osteoporosis. Prospective recruitment and chart abstractions from family practices of three University affiliated hospitals were completed for women aged 45 years or more with baseline bone mineral density (BMD) testing results by dual energy X-ray absorptiometry. Those taking bone active medication other than hormone therapy, with prior fragility fracture or with risk factors for secondary osteoporosis were excluded. Women were categorized as being normal, osteopenic or osteoporotic by lowest BMD T-score at either the femoral neck or lumbar spine (L1-L4). Sensitivity, specificity and area under the receiver operating characteristic (ROC) curve to identify those with osteoporosis were determined for each decision rule. The positive predictive value (PPV) for detecting osteoporosis after using a second cut point to convert each decision rule into a risk index (low, moderate or high risk) was also determined. The sensitivity of the decision rules to identify women with osteoporosis ranged from 92% to 95% and specificity from 35% to 46%. The area under the ROC curves were significantly better for the ORAI (0.80), OST chart (0.82) and OST equation (0.82) compared with the body weight criterion (0.73). PPV for detecting osteoporosis ranged from 30% to 58% among women deemed at high risk. These data confirm the validity of the ORAI, the OST chart and the OST equation as screening tools for BMD testing. Further evidence is required to confirm the validity of the body weight criterion.</abstract><cop>London</cop><pub>Springer</pub><pmid>14730421</pmid><doi>10.1007/s00198-003-1552-7</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0937-941X
ispartof Osteoporosis international, 2004-05, Vol.15 (5), p.361-366
issn 0937-941X
1433-2965
language eng
recordid cdi_proquest_miscellaneous_71856455
source MEDLINE; SpringerLink Journals
subjects Absorptiometry, Photon
Age Factors
Aged
Ambulatory care
Asymptomatic
Biological and medical sciences
Bone density
Decision making
Decision Support Techniques
Diseases of the osteoarticular system
Endocrine therapy
Epidemiologic Methods
Female
Fractures
Health sciences
Humans
Mass Screening - methods
Medical sciences
Middle Aged
Osteoporosis
Osteoporosis, Postmenopausal - diagnosis
Osteoporosis, Postmenopausal - etiology
Osteoporosis. Osteomalacia. Paget disease
Patient Selection
Risk assessment
Risk Assessment - methods
Risk factors
Validity
Womens health
title The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T22%3A01%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20validity%20of%20decision%20rules%20for%20selecting%20women%20with%20primary%20osteoporosis%20for%20bone%20mineral%20density%20testing&rft.jtitle=Osteoporosis%20international&rft.au=CADARETTE,%20Suzanne%20M&rft.date=2004-05-01&rft.volume=15&rft.issue=5&rft.spage=361&rft.epage=366&rft.pages=361-366&rft.issn=0937-941X&rft.eissn=1433-2965&rft_id=info:doi/10.1007/s00198-003-1552-7&rft_dat=%3Cproquest_cross%3E71856455%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218856431&rft_id=info:pmid/14730421&rfr_iscdi=true